Initial Treatment for Severe Hypercalcemia

Severe hypercalcemia is a serious condition requiring prompt management. The primary goal is to lower the serum calcium level quickly and safely.

Rationale for Normal Saline Infusion

Intravenous (IV) infusion of normal saline (0.9% NaCl) is considered the most appropriate initial treatment for severe hypercalcemia for the following reasons:

• Volume Expansion: Saline expands the extracellular fluid volume, which helps to dilute the calcium concentration.
• Promotes Calciuresis: The increased sodium and chloride load delivered to the kidneys enhances the excretion of calcium in the urine (calciuresis). This effect is potentiated by the increased glomerular filtration rate associated with adequate hydration.

Evaluation of Other Options

While other treatments exist, they are typically not the first choice for initial management:

• Intravenous infusion of pamidronate: Bisphosphonates like pamidronate are effective in lowering calcium levels but generally take 24-48 hours to show their full effect. They are usually administered after initial hydration with saline.
• Oral phosphate supplementation: This is generally contraindicated in severe hypercalcemia as it can lead to rapid, potentially fatal, systemic calcification, especially in the kidneys and other vital organs.
• Hemodialysis: This is a rapid but invasive method reserved for patients with severe hypercalcemia who do not respond to other treatments, have significantly impaired renal function, or have volume overload. It is not the standard initial therapy.

Therefore, intravenous infusion of normal saline is the cornerstone of initial management for severe hypercalcemia due to its immediate physiological effects of promoting volume expansion and increasing calcium excretion.